Blog

Peer Review Doesn’t Apply in False Claims Act Suit

Massachusetts General Hospital could not assert the medical peer review privilege to block production of documents sought by a whistleblower in her False Claims Act suit over the hospital’s alleg...

Geissler v. Sterling

District of South Carolina. GBB lawyers contributed to this class action lawsuit, filed against the Department of Correction, alleging that South Carolina prisoners recieved inadequate testin...

Free Virtual Seminar by Online Courtroom Project and NITA

As courts around the country have struggled to continue operations in the face of the unprecedented coronavirus pandemic, each state and the federal courts have issued their own set of guidelines...

Wisconsin Based APM Settles FCA Suit

The DOJ accounted that federally funded Advanced Pain Management Holdings Inc. and its subsidiaries, collectively called APM Entities, have agreed to pay the government $885k to settle a qui tam...

Oral Roberts University, $300,000

United States ex rel. Shoe v. Oral Roberts University, District of South Carolina. GBB attorney's brought this False Claims Act case against Oklahoma based ORU alleging that the university ha...

Boeing Company, $40 million

US Ex Rel. Roby v. Boeing Co., Southern District of Ohio. Firm attorneys represented the relator in this False Claims Act suit alleging that the Boeing Company defrauded the US Government by...

Lockheed Martin, $5 million

United States, ex rel. John David Tillson, Natural Resources Defense Council, Inc., et al. v. Lockheed Martin Corp., et al., Western District of Kentucky. Lawyers with our firm represente...

Northwell Health, $12 million

United States of America ex rel. George Markelson, et. al. v. David B. Samadi, M.D. and Northwell Health, Inc. et al., Southern District of Florida. GBB attorneys represented one of three whi...

Humana Inc., $7 million

U.S., ex rel. Graves v. Plaza Med. Centers Corp., Humana Inc., and Michael Cavanaugh, Southern District of Florida. Our attorneys contributed to a qui tam action alleging that defendant Micha...

Bank of America, $95 million

U.S. ex rel. Szymoniak v. Bank of America, et al., District of South Carolina / Western District of North Carolina. Firm attorneys played a role in a False Claims Act recovery from mortgage s...

Amgen, $24.9 million

U.S. ex rel. Kurnik v. Amgen, Inc., et al., District of South Carolina. Firm attorneys represented Relator Frank Kurnik, in a case where pharmaceutical giant Amgen was alleged to have paid ki...

Pfizer (Rapamune), $257.4 million

U.S. ex rel. Sandler and Paris v. Wyeth Pharmaceuticals and Pfizer, Inc., Eastern District of Pennsylvania. The firm’s attorneys served as lead counsel for two whistleblowers who alleged mar...

Pfizer, $2.3 billion

U.S. ex rel. Demott v. Pfizer, District of Massachusetts. Firm attorneys represented one of six whistleblowers who revealed information to the government that resulted in an overall $2.3 bill...

GlaxoSmithKline, $1.04 billion

U.S. ex rel. Graydon v. GlaxoSmithKline, District of Massachusetts. Firm attorneys served as lead counsel for whistleblowers alleging that GlaxoSmithKline (GSK) engaged in illegal promotion o...

Community Health Systems, $97 million

U.S. ex rel. Doghramji, et al. v. Community Health Systems Inc., et al., Middle District of Tennessee. Firm attorneys represented three relators in a case alleging healthcare fraud by Tenness...

Abbott Labs, $1.6 billion

U.S. ex rel. McCoyd v. Abbott Laboratories, Western District of Virginia. The firm’s attorneys, in conjunction with state and federal governments, pursued claims against Abbot Laboratories, a...
1 2 3 6